Suppr超能文献

一例氯氮平所致肝毒性:管理考量与未来方向

A Case of Clozapine-Induced Hepatotoxicity: Management Considerations and Future Direction.

作者信息

Bulkley Matthew B, Oberdorfer Kendahl, Maan Renee R

机构信息

Psychiatry, Wayne State University School of Medicine, Detroit, USA.

Psychiatry, Henry Ford Health System, Detroit, USA.

出版信息

Cureus. 2024 Oct 3;16(10):e70788. doi: 10.7759/cureus.70788. eCollection 2024 Oct.

Abstract

Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia. Its use is often limited due to its well-known association with a variety of side effects. Hepatotoxicity is a less common side effect and has been infrequently reported. Here, we present the case of a patient who developed abdominal discomfort and right upper quadrant pain after clozapine was initiated. Liver transaminases were found to be elevated and continued to rise despite cessation of another psychiatric medication more commonly associated with hepatotoxicity. Discontinuation of clozapine resulted in relief of symptoms and normalization of liver enzymes without any complications.

摘要

氯氮平是一种用于治疗难治性精神分裂症的非典型抗精神病药物。由于其与多种副作用的众所周知的关联,其使用常常受到限制。肝毒性是一种较不常见的副作用,且鲜有报道。在此,我们报告一例患者,在开始使用氯氮平后出现腹部不适和右上腹疼痛。尽管停用了另一种更常与肝毒性相关的精神科药物,但发现肝转氨酶升高且持续上升。停用氯氮平后症状缓解,肝酶恢复正常,且无任何并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6786/11531323/68bc403e75f8/cureus-0016-00000070788-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验